CENDARA Bioscience is a specialist pharma advisory firm that partners with pharmaceutical sponsors from the earliest stage of Phase 1 process development all the way through to final CDMO selection and programme completion. We deploy embedded expert resource to manage the combined sponsor-CDMO team, compress development timelines by 30–60%, and generate fees only when we deliver measurable value. Our mission is to eliminate the wasted months that cost pharmaceutical companies tens of millions of dollars and accelerate the path from outsourcing decision to commercial manufacture.
Our Expertise
Our team combines deep pharma manufacturing experience, CDMO operations knowledge, and digital process innovation. We have guided sponsors through Phase 1 process development, CDMO selection, technology transfer, and commercial readiness across small molecules, biologics, and advanced therapies. Every engagement is structured around verified programme acceleration and measurable value creation.
